LC
ETNB

Lindbrook Capital’s 89bio ETNB Stock Holding History

Lindbrook Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$39 – 2827
2024
Q4 		$39 Sell
5
-103
-95% -$848 ﹤0.01% 2758
2024
Q3 		$799 Buy
108
+46
+74% +$387 ﹤0.01% 2556
2024
Q2 		$497 Sell
62
-536
-90% -$4.79K ﹤0.01% 2598
2024
Q1 		$6.96K Buy
598
+333
+126% +$3.69K ﹤0.01% 1751
2023
Q4 		$2.96K Sell
265
-402
-60% -$3.69K ﹤0.01% 2120
2023
Q3 		$10.3K Buy
667
+468
+235% +$7.86K ﹤0.01% 1401
2023
Q2 		$3.77K Hold
199
– – ﹤0.01% 1925
2023
Q1 		$3.03K Hold
199
– – ﹤0.01% 2071
2022
Q4 		$2.53K Buy
+199
New +$1.79K ﹤0.01% 2127

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's ETNB Position: Q1 2025 in Review

Lindbrook Capital sold out of 89bio (ETNB) in Q1 2025, closing a stake of 5 shares — an estimated $39 sold.

Lindbrook Capital first reported a position in ETNB in Q4 2022 and held it in 9 quarters. The position peaked at $10.3K in Q3 2023. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • Lindbrook Capital reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 5 89bio shares in Q1 2025, an estimated $39.
  • Lindbrook Capital first reported a position in 89bio in Q4 2022 and held it in 9 quarters.
  • Lindbrook Capital's 89bio position peaked at $10.3K in Q3 2023.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.